Point-of-care fluorescence imaging reveals extent of bacterial load in diabetic foot ulcers
David G. Armstrong1, Michael E. Edmonds2, Thomas E. Serena3
1Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California, USA 2Diabetic Foot Clinic, King's College Hospital Foundation Trust, London, UK 3SerenaGroup®Research Foundation, Cambridge, Massachusetts, USA
International Wound Journal, Volume 20, Issue 2, Feb. 2023, PP 554-566
Related Publications
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.